Dhaka, June 19 -- Trading of Beximco Pharmaceuticals on the London Stock Exchange's sub-market Alternative Investment Market (AIM) has remained suspended for five and a half months after it failed to publish audited financial statements in time, with the company now just two weeks away from potential delisting.

Bangladesh Securities and Exchange Commission (BSEC) Chairman Masud Khan said efforts are under way to prevent the company's removal from the LSE, warning that delisting would damage Bangladesh's capital market reputation.

"The next two weeks are critical. We must do something so that Beximco Pharma is not delisted from the London Stock Exchange," he told bdnews24.com on Thursday.

"If it is delisted, it will damage the country's...